Nature’s Sunshine Products, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Income Per Share

Net Income Per Share

9 Months Ended

Sep. 30, 2023

Basic net income per common share (“Basic EPS”), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.

Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September 30, 2023 and 2022 (dollar and share amounts in thousands, except for per share information):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022



Net income (loss) attributable to common shareholders	$	2,832	$	90	$	6,114	$	(2,344)

Basic weighted average shares outstanding	19,133		19,198		19,093		19,384




Basic earnings (loss) per share attributable to common shareholders	$	0.15	$	—	$	0.32	$	(0.12)

Diluted shares outstanding:
Basic weighted-average shares outstanding	19,133		19,198		19,093		19,384
Stock-based awards	359		284		357		—
Diluted weighted-average shares outstanding	19,492		19,482		19,450		19,384




Diluted earnings (loss) per share attributable to common shareholders	$	0.15	$	—	$	0.31	$	(0.12)

Dilutive shares excluded from diluted-per-share amounts:
Share-based awards	735		576		735		—

Anti-dilutive shares excluded from diluted-per-share amounts:
Share-based awards	25		25		50		576		(1)

_________________________________________

(1) As a result of the net loss for the nine months ended September 30, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the nine months ended September 30, 2022 include 576 restricted stock units.

Potentially dilutive shares excluded from diluted-per-share amounts include performance-based restricted stock units, for which certain metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted-average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.